Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-03

Clinical Trial Update: Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis [Phase 3]

View source ↗

Summary

This document describes an ongoing Phase 3 trial evaluating the combination of etoricoxib and betamethasone for acute gout arthritis, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Betamethone (betamethasone)
  • Etoricoxib (etoricoxib)

Snippet

Sponsor: Laboratorios Silanes S.A. de C.V. | Conditions: Gout Arthritis, Gout Attack | Phase 3 | Status: RECRUITING